AKT1 and cancer: Thus, we hypothesized that IFN-exo or miR-106b-3p regulated the malignant biological functions of cancer cells by reducing the PCGF3 expression and inhibiting PI3K/AKT signaling pathway activity in HBV (+)-HCC.